Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related products set out in the Schedule hereto:
Schedule
Product: Redken 5th Avenue NYC Scalp Chemistry Dandruff Control Shot for Dandruff Prone Scalp
Active Ingredient: Salicylic acid 3%w/v
Dosage Form: Scalp lotion
New Zealand Sponsor: L’Oreal New Zealand Limited
Manufacturer: L’Oreal Products USA Inc., Somerset, United States of America
Product: Redken 5th Avenue NYC Scalp Relief Anti-Dandruff Conditioner for Dry, Flaking Scalp& Hair
Active Ingredient: Pyrithione zinc 0.9898%w/v
Dosage Form: Scalp lotion
New Zealand Sponsor: L’Oreal New Zealand Limited
Manufacturer: L’Oreal Products USA Inc., Florence, United States of America
Product: Redken 5th Avenue NYC Scalp Relief Anti-Dandruff Shampoo for Dry, Flaking Scalp & Hair
Active Ingredient: Pyrithione zinc 0.9898%w/v
Dosage Form: Shampoo
New Zealand Sponsor: L’Oreal New Zealand Limited
Manufacturer: L’Oreal Products USA Inc., Florence, United States of America
Product: Redken 5th Avenue NYC Scalp Relief Dandruff Control Leave-In Treatment for Dry Flaking Scalp & Hair
Active Ingredient: Pyrithione zinc 0.1008%w/v
Dosage Form: Scalp lotion
New Zealand Sponsor: L’Oreal New Zealand Limited
Manufacturer: Medicia Corporation, Dayton, United States of America
Dated this 1st day of November 2007.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).